Podcasts about ACR

In this episode, we explore a new approach to improving participation in lupus clinical trials by strengthening provider outreach and education. Our guest, Dr. Saira Sheikh of UNC Chapel Hill, discusses the TIMELY study, which focuses on involving healthcare providers and community health workers to better connect patients with trial opportunities. From roundtable discussions to changes in provider behavior, we highlight practical strategies that could improve how clinical trials are conducted. 

Not sure what Minimal Disease Activity or MDA is and how it relates to psoriatic arthritis and your joints? Listen as rheumatologist Dr. Arthur Mandelin explains what MDA means. Join hosts Jeff Brown and LB Herbert as they discuss minimal disease activity in psoriatic arthritis with nationally recognized rheumatologist Dr. Arthur Mandelin who identifies what it is, factors that influence achieving MDA, how long it takes to reach, and the impact on selection of treatments. Dr. Mandelin also addresses fatigue associated with inflammation, and what the future holds for minimal disease activity in psoriatic arthritis. Whether you have psoriasis or psoriatic arthritis, this episode offers information to help you understand management goals set by your doctor and the importance of attaining minimal disease activity. Timestamps: (00:00) Intro to Psound Bytes & guest welcome rheumatologist Dr. Arthur Mandelin (02:23) What is minimal disease activity (MDA) (04:32) MDA in comparison to ACR response criteria (07:36) Criteria for reaching MDA (09:20) Positive and negative factors of MDA (11:25) Importance of reaching MDA within a specific time frame (17:34) Length of time to reach MDA (18:48) Selection of treatment options and psoriatic arthritis domains (23:51) Inflammation and fatigue (26:59) A look at the future of minimal disease activity in psoriatic arthritis: Reaching ACR 90 (29:09) Advancements in psoriatic arthritis: Finding disease markers (33:40 ) If you have psoriasis, be aware of your risk for psoriatic arthritis 4 Key Takeaways: There are various ways to measure minimal disease activity in psoriatic arthritis to assess how the disease impacts quality of life.   Attaining and keeping minimal disease activity low through use of different therapy options offers a chance for better bone and joint outcomes. Advancements in psoriatic arthritis include attaining ACR90 and the potential for identifying key markers that make treatment selection more targeted and individualized. Those who have psoriasis need to realize bone and joint pain, and swelling in the joints may be related to their psoriatic skin disease and seek appropriate help.  Guest Bio: Dr. Arthur Mandelin is an Associate Professor of Medicine at Northwestern University Feinberg School of Medicine and the Department of Medicine Division of Rheumatology. Dr. Mandelin launched Northwestern University's first training program in musculoskeletal ultrasonography for rheumatology fellows. He is an active participant in the REASON Group which is a multi-center research collaboration devoted to using ultrasound guidance to obtain minimally invasive synovial tissue biopsies. Dr. Mandelin is a past member of the National Psoriasis Foundation's Medical Board where he served on consensus panels for the development of a variety of practice guidelines.  Resources Mentioned: National Psoriasis Foundation: https://www.psoriasis.org PEST Screener: https://www.psoriasis.org/psoriatic-arthritis-screening-test/ PsA Action Month 2025: https://www.psoriasis.org/psa-action-month/ NSAIDS  for Psoriatic Disease: https://www.psoriasis.org/advance/nsaids-for-psoriatic-disease-psa/ AMP (Accelerated Medicines Partnership): https://www.psoriasis.org/advance/progress-and-success- through-collaboration/  Tags: psoriasis, skin, psoriatic arthritis, minimal disease activity, ACR20, ACR50, ACR70, tender joints, bone erosion, joint swelling, enthesitis, inflammation, pain, fatigue, axial disease, spinal involvement, treatment, NSAIDS, biologics, personalized medicine, dermatology, National Psoriasis Foundation, AMP, Psound Bytes podcast, Soundbites podcast

Topic begins at (0:02:03) mark: Sportsbettor Thomas McPeek claims Caesars in Indiana and Iowa refused to pay him rightfully won $800k worth of sports bets.... (1:24:45): PropSwap massively bungles social media response to customer who got cheated by another user.... (2:21:46): ACR fires Nacho Barbero after Nacho admits on PokerGo that the site isn't trying to catch cheaters.... (2:35:23): Harvey's Lake Tahoe to become "Caesars Republic Lake Tahoe", but what is Caesars Republic?.... (2:56:10): Evan Glusman, son of owner of iconic Vegas restaurant Piero's, accused of threatening to kill employees and own father after getting fired for allegedly taking out an unauthorized loan against the business.

This episode explores the evolving role of GLP-1 agonists in rheumatology, highlighting their potential to influence weight, inflammation, and overall disease activity. Our guest expert unpacks how adipose tissue contributes to systemic inflammation and why managing body weight is crucial in the treatment of rheumatic diseases. We delve into the underlying science, real-world clinical applications, and the exciting future of incorporating GLP-1 therapies into comprehensive rheumatologic care—offering fresh insight into a therapeutic class with game-changing potential. 

TECH CLUBBERS PODCAST W/ ANSWER CODE REQUEST Patrick Gräser, better known as Answer Code Request, has carved out a distinctive niche in the techno landscape with his hybrid musical style. His innovative approach, characterized by a fusion of pad-driven harmonies, intricate breaks, and an industrial tone, has set him apart since his emergence on the esteemed Ostgut Ton label in 2012. This breakthrough led to a prestigious residency at Berghain, further cementing his influence in the scene. Gräser's work, including various releases and remixes for notable labels such as Ostgut Ton, MDR, Dolly Deluxe, and Monkeytown Records, has garnered widespread acclaim. Gräser's journey from a forest workshop near his hometown to the forefront of techno is marked by his wide-ranging musical tastes. His nights, spent mixing records from Hardwax and Delirium, contributed to the development of his characteristic sound, a blend that includes elements of jungle, drum ‘n' bass, Detroit, IDM, and UK bass. This unique amalgamation of styles is evident in his early releases on Music Man and his own ACR imprint, showcasing a talent that transcends traditional techno boundaries. Follow ANSWER CODE REQUEST here: Facebook: https://www.facebook.com/answercoderequest Instagram: https://www.instagram.com/answercoderequest Soundcloud: https://soundcloud.com/answercoderequest

Si queremos ser eficientes económica, social y ambientalmente debemos conseguir que la construcción evolucione hacia un modelo industrial, en el marco de una relación colaborativa entre el mundo de la Ingeniería y la Arquitectura”. En estos términos se ha expresado Roberto Albaizar, Director de Desarrollo Corporativo del grupo ACR, constructora española pionera en tecnología y sostenibilidad, con quien hemos hablado del presente y las perspectivas de futuro del sector de la construcción en nuestro país.

In this episode, we dive into the evolving role of AI in rheumatology—exploring how it's already reshaping workflows, enhancing diagnostic accuracy, optimizing treatment selection, and helping us monitor patients remotely. We tackle big questions around bias, control over critical data and whether we're truly ready to let AI serve as our assistants—or even gatekeepers. From addressing workforce shortages to revolutionizing medical research and education, we examine both the promise and the pitfalls of this powerful technology, and why caution must guide its integration into our clinical decisions.

In this episode of PTs Snacks podcast, host Kasey delves into osteoarthritis (OA), clearing up common misconceptions and explaining its impact on physical therapy. Kasey emphasizes the importance of addressing patients' self-limiting beliefs about OA and highlights the necessity of educating them about the true nature of the condition. The episode covers the basics of osteoarthritis, including its degenerative nature, contributing factors, and commonly affected joints. Kasey stresses that OA is not solely about cartilage loss and isn't always progressive, with exercise and physical therapy playing crucial roles in managing symptoms and improving patients' quality of life. The episode also touches on situations where patients may need to be referred for surgical consultations or further medical evaluation. Kasey wraps up by providing resources and recommendations for further learning, including guidelines from OARSI, ACR, and NICE, as well as courses available on MedBridge.00:00 Introduction and Podcast Overview00:55 Understanding Osteoarthritis03:30 Common Misconceptions About Osteoarthritis04:13 Physical Therapy for Osteoarthritis05:45 Empowering Patients and Setting Goals07:45 When to Consider Surgical Consults09:15 Conclusion and Additional ResourcesRelevant MedBridge Courses1. Management of Knee Osteoarthritis – Megan Mitchell, PT, DPT 2. Osteoarthritis: Clinical Pathways – Eric Robertson, PT, DPT, PhDSupport the showWhy PT Snacks Podcast?This podcast is your go-to for bite-sized, practical info designed for busy, overwhelmed Physical Therapists and students who want to build confidence in their foundational knowledge without sacrificing life's other priorities. Stay Connected! Never miss an episode—hit follow now! Got questions? Email me at ptsnackspodcast@gmail.com or leave feedback HERE. Join the email list HERE On Instagram? Find unique content at @dr.kasey.hankins! Need CEUs Fast?Time and resources short? Medbridge has you covered: Get over $100 off a subscription with code PTSNACKSPODCAST: Medbridge Students: Save $75 off a student subscription with code PTSNACKSPODCASTSTUDENT—a full year of unlimited access for less!(These are affiliate links, but I only recommend Medbridge because it's genuinely valuable.) Optimize Your Patient Care with Tindeq Looking for a reliable dynamometer to enhance your clinical measurements? Tindeq ...

Watch the Podcast Video on our YouTube Channel No business can operate with zero emissions, there's only so much you can reduce before you need to look at offsetting the remainder to truly achieve Net Zero. Carbon offsetting comes in many forms, but the ones people will be most familiar with include purchasing carbon credits for nature restoration projects and tree planting efforts. Historically, the voluntary carbon market has been troubled by project developers who haven't operated their carbon offsetting projects to the environmental and social standards expected by buyers. With the use of offsets on the rise, it's clear that there is a need for transparency and standardisation within these voluntary markets. In this episode Mel is joined by Tiffany Cheung, the Corporate Engagement Lead at AlliedOffsets, to explain what the voluntary carbon market is, how carbon credits work from purchase to retirement and what quality controls are in place to ensure they are reliable. You'll learn ●       Who are AlliedOffsets? ●       What is the voluntary carbon market? ●       What are carbon credits, and how do they work? ●       What quality controls are in place for carbon credits? ●       How will the voluntary carbon market affect future regulatory requirements? ●       What does it mean to retire a carbon credit? ●       What services do AlliedOffsets offer?   Resources ●       AlliedOffsets website ●       AlliedOffsets LinkedIn ●       Carbonology   In this episode, we talk about: [00:30] Episode Summary – Tiffany Cheung joins Mel to discuss the voluntary carbon market, explaining the carbon credit lifecycle and what quality controls are in place to ensure they are reliable. [01:40] Who are AlliedOffsets?: AlliedOffsets aggregates data from over 30 carbon registries and compliance schemes as well as off-registry transactions to present the most comprehensive dataset on carbon offsetting activity globally. Their data has been featured in publications such as the Financial Times, Forbes, The Guardian and many more. [03:20] How did Tiffany get involved in carbon markets?: Tiffany has been working with AlliedOffsets for over a year, and a lot of their role as Corporate Engagement Lead includes talking to a variety of stakeholders on the buying side of the carbon market, understanding what their motivations for being in the space are, what their strategies are going into the future and their wider decarbonisation process. Tiffany also looks at their transactional activity and how that has changed over time. Prior to their position at Allied Offsets, Tiffany worked in a major environmental advisory and brokerage firm based in London. There they gained a knowledge of both voluntary carbon markets as well as renewable energy markets in that space, this in addition to learning more about the accompanying compliance trading and risk side of things. [06:00] What is the carbon market?: Carbon markets describe markets where carbon is translated from a greenhouse gas into an asset, or a commodity that can be traded. These tend to represent actual tonnes of atmospheric carbon dioxide that have been sequestered somewhere else in the world through various projects. Compliance carbon markets work differently from voluntary carbon markets. Compliance carbon markets provide regulated ways of pricing carbon, both in terms of reducing emissions and generally making polluters aware of the environmental impact of their emissions in a financial way. They may be associated with the voluntary carbon market, also known as the VCM, or they may be referred to as a kind of carbon tax. [07:05] What's the difference between a voluntary carbon market and a non-voluntary carbon market? If you are engaging in the voluntary carbon market, there is no legislative impetus for you to be involved in it. It's mostly driven by a business' own desire to offset emissions. The offsetting of residual emissions is done through the purchase of carbon credits, which are representative of 1 tonne of CO2 equivalent removed from the atmosphere. If you offset all of your remaining emissions, then you may be able to claim carbon neutrality for the year that the credits apply to. The benefits of carbon credit-issuing projects aren't always related to solely greenhouse gas removal, and depending on a businesses motivations, you can help to fund a wide range of beneficial projects such as clean water provision or improved cook stoves which improve air quality in domestic settings. [09:25] What type of organisations are leading the way with carbon credit purchasing? – AlliedOffsets has unique access to the transaction history across 30 different global registries, enabling them to provide an up to date and wide ranging view on the voluntary carbon market. There is a very strong relationship between how polluting a sector is and how well engaged it is with the voluntary carbon markets. So major players include energy producers, aviation, maritime, ground transportation and mining and materials. There is also an increase in financial services, technology and telecommunications services entering the carbon market. Tiffany expects this trend to continue with increased data centre usage and artificial intelligence driving up energy consumption across these sectors. [11:10] How does the voluntary carbon market operate?: When a company first decides they want to buy carbon credits, ideally they would engage with a well-established broker or intermediary who can source a variety of carbon credits. It's helpful for the broker to know what sort of carbon credits or projects a company is looking to invest in. There's a lot of different options, including: ●       Forestry ●       Alternative land use ●       Blue Carbon ●       Engineered carbon dioxide removal The company will let the broker know how many tonnes of carbon credits they'd like to buy, attributed to a certain period of time or activity based on their quantification and existing carbon reporting. Market prices will range quite significantly based off of what technology type or methodology you're going with, but most carbon credits are currently sub $15. Once agreed, your intermediary will secure and retire the credits for you, from the registry and project developer. Retiring a carbon credit means they are taken entirely off the market and they're considered to be “spent” or used. Nobody else can use those as an investment or offset at that point, and the purchasing company can consider their carbon footprint to have been neutralised for the specified period. [12:00] What quality controls are in place for the voluntary carbon market? While there isn't a master registry, there are several registries across the world that generally dominate the market. They vary in terms of the methodologies that they may or may not specialise in, as well as with geographies. The biggest ones that you're most likely to see in the market are known as VCS, GS, ACR, and CAR. These account for about 80% of the total market volume by retirement and issuance. The way that these registries work is that they perform a bookkeeping function within the space. Projects will register their sequestered tonnes of CO2 removed with these registries, who will then check to see if these projects have complied with their methodology, which would have been set by a Standards Body. Once approved, those project developers can sell their credits as a commodity. When a business wants to buy credits, the type of projects they want to engage with will dictate the sort of registries they'll be engaging with. There are also checks in place set by the registries to ensure that project developers use third parties to further validate their project activities. [16:45] What are the methodologies used in the voluntary carbon market? A methodology refers to the way in which a specific project should be undertaken in order to ensure that the pace of carbon sequestration and storage is consistent throughout the project's life. Registries are ultimately responsible for issuing the appropriate methodology, and the project developers need to be able to evidence compliance to that methodology. The process for a project to be registered is quite complicated, and it generally takes 2 – 3 years from concept to being in a position to issue credits. There is also a requirement to have their work validated by a Verification and Validation Body (VVB). These are third party auditors who check the evidence provided by project developers to ensure they comply with the necessary methodology. This may include the VVBs undertaking a site visit. [19:30] Will regulatory requirements be introduced within the voluntary carbon market?  – Tiffany states that there is definitely a demand for regulatory requirements in the space. There a two key drivers for this: The need for integrity among buyers – There are many sectors where engaging in a more unregulated space can be risky. Sectors such as the legal and financial sectors need a certain level of oversight to ensure they are making sound investments. Convergence of compliance and voluntary markets – This is a change that's been happening over the past few years. This is being driven by governments taking part in the voluntary carbon market space and realising that they can yield returns for the country. Additionally, when they're spending public funds, there needs to be a certain level of assurance in the projects they're engaging with. There is also a growing appetite for businesses engaging in this market to ensure that they are doing the best thing possible ahead of the curve. There's been a lot of negative press around greenwashing projects, leading to potentially tarnished reputations, to the need for proper checks and regulation is becoming a necessity.  [22:45] What does it mean for a carbon credit to be retired? – The point at which a carbon credit is retired is when it has been taken totally out of circulation for the market. That means that no other broker, intermediary or end buyer would be able to use that credit in any kind of capacity. It's like having the receipt to say this person has purchased this product, it belongs to them now and nobody else can use it.   [24:30] How are stakeholders using the data provided by AlliedOffsets? – AlliedOffsets has a very wide data set, with an equally wide range of stakeholders. Some particularly interesting use cases include: Benchmarking against the competition – Corporate buyers use their data to compare how their activity measures up to competitors or peers within their sector due to AlliedOffsets long view of historic activity. It highlights what projects are being favoured by their competitors and what kind of price points they should be looking at as well. Project developer research - Another common use case is that project developers will want to see who is active in the market and who they should be targeting for funding. AlliedOffsets can see specific buyer activity broken down by region as well as methodology, which means project developers have a really good chance of being able to engage with buyers who are entering the space and might not have established those direct procurement relationships. Government consultation - Markets can be a huge source of income from the private sector into the public purse. For example, you might have a voluntary carbon market scheme that's associated with a compliance scheme, which can mean tax benefits for complying businesses alongside socio-environmental benefits for the country. If you'd like to learn more about AlliedOffsets, visit their website or reach out to Tiffany for more about buyer activity in the VCM! If you'd like any assistance with carbon standards, get in touch with Carbonology, they'd be happy to help! We'd love to hear your views and comments about the ISO Show, here's how: ●     Share the ISO Show on Twitter or Linkedin ●     Leave an honest review on iTunes or Soundcloud. Your ratings and reviews really help and we read each one. Subscribe to keep up-to-date with our latest episodes: Stitcher | Spotify | YouTube |iTunes | Soundcloud | Mailing List

On this episode, we chat with Dr. Sho Fukui about his recent study on rising uric acid levels and what's driving the increase. We dig into the links between weight, obesity, and gout, and hear how a huge health checkup database in Japan helped uncover some eye-opening trends. Dr. Fukui breaks down the findings in simple terms, shares how they compare to older studies like MRFIT, and talks about what they could mean for treatments like GLP-1s. Plus, we get a sneak peek at the exciting research he's working on next! 

This is part 2 of the episode from 4/1/25.... Topic begins at (0:07:54) mark: Mojave Desert and Las Vegas History: Barbary Coast, Bill's, The Cromwell, and soon... Vanderpump?!.... (0:38:08): Ebony Kenney is the latest "goofball" ACR pro to have been caught using GTO Wizard during the ACR Venom series.... (1:02:08): Maurice Hawkins gets boost by eliminating player with 3 left at WSOP Circuit event, despite having worst hand.... (1:31:32): Update: George Janssen, who claimed he was kidnapped and extorted for money, under investigation by FBI for faking story & stealing from banks.... (1:42:51): Ali Imsirovic BANNED from Texas "Champions Club" for being a general poker cheat.... (1:48:24): GGPoker buys Nick Vertucci's share of Hustler Casino Live.... (1:57:01): Mike Holtz alleges Resorts World allowed two Spanish pros to get away with blatantly cheating.... (2:18:48): Move over Terrrance Watanabe!! Bruno Mars might have lost over $100m to MGM properties.... (2:29:21): MGM Rewards modifies program to give more benefits starting March 25.... (2:42:47): Whiskey Pete's gets waiver to remain closed, retain license through December 2026, plus LV might get new airport.

In this episode, we dive into the complexities of IgG4-Related Disease (IgG4-RD), a mysterious and multi-organ condition that continues to challenge both patients and physicians. Back in January 2024, Dr. John Stone introduced us to the emerging landscape of treatments for IgG4-RD, and today, Dr. Matthew Baker joins us to provide an exciting update. With new therapies on the horizon, we explore the role of B and T cell pathogenesis, the limitations of traditional steroid treatments, and the off-label use of rituximab. We also take a closer look at the promising results from the “Mitigate Trial,” which offers hope for future strategies in managing this enigmatic disease. Join us as we discuss the evolving treatment landscape and what lies ahead for those affected by IgG4-RD. 

Da oltre un decennio, in molti televisori è annidata una funzione che cattura l'immagine di quello che c'è sullo schermo e ne manda una sintesi a un archivio centralizzato a scopo commerciale. Si chiama ACR, e ovviamente ha delle enormi implicazioni di privacy ed è fonte di continua irritazione degli utenti che si trovano bombardati di pubblicità. Vediamo come funziona, come localizzarla e soprattutto come disattivarla.

In this episode, we're joined by Dr. Atul Deodhar, a leading expert in the field of Axial Spondyloarthritis (AxSpA). Dr. Deodhar shares insights from his groundbreaking research on the pathophysiology, diagnosis, and management of AxSpA, particularly focusing on the efficacy and safety of IV secukinumab. We dive deep into his study, INVIGORATE-1, exploring the methods behind it, including the use of Interactive Response Technology, and the primary and secondary endpoints that shed light on this treatment's impact. We also discuss the latest data on patient preferences for subcutaneous versus intravenous immunomodulators and the implications of these findings. Tune in for an informative and engaging conversation that blends cutting-edge science with thoughtful reflections on patient care. 

In this episode, we dive into a fascinating and often overlooked aspect of rheumatology: complications from diabetes that can mimic rheumatic diseases. Dr. Schiopu kicks off the discussion by shedding light on Diabetic Myonecrosis, a painful muscle condition that can be easily mistaken for other rheumatic disorders. We then explore Scleroderma, a skin-thickening muscle disorder that resembles systemic sclerosis (SSC) but has distinct underlying mechanisms. Dr. Schiopu shares invaluable insights on how to approach complex rheumatology consults in the hospital, emphasizing the importance of thoughtful diagnostic reasoning. She also discusses why sometimes the best approach in medicine is to avoid unnecessary tests and treatments, prioritizing patient care and accuracy in diagnosis. 

This week, we explore the genetics behind the production of antinuclear antibodies (ANA) in individuals without clinical autoimmune disease, using data from the All of Us registry. Our guest, Dr. Mehmet Hocaoglu shares insights into the significance of understanding ANA positivity and its potential genetic underpinnings, highlighting how large-scale genome-wide association studies (GWAS) can predict susceptibility to autoimmune conditions. We cover the study's methodology, the unique All of Us dataset, and the complexities of genetic analysis. Dr. Hocaoglu also discusses his personal journey in rheumatology research, offering advice for aspiring researchers, especially international medical graduates (IMGs).  

In this episode, we introduce the rest of the Blue Ribbon Panel and interview our friends from NephMadness about their CAR-T region.Remember, RheumMadness brackets are open through March 31 at 11:59pm ET!  Submit your brackets here.First time playing RheumMadness? Check out our new explainer video!Blue Ribbon Panelists in this episode:Anastasiya (Stacy) Bagrova, MD completed internal medicine residency at Duke, rheumatology fellowship at the University of South Florida, and is now a practicing rheumatologist in Clearwater, FL. Similar to her clinical practice, her clinical interests in rheumatology are broad.  Follow her on X at @asbagrova.Eric Dein, MD, is currently living in Jersey City, NJ – hometown of the March Madness great Cinderella St Peter's Peacock team. He is currently practicing rheumatology at Atlantic Health System at Overlook Hospital in Summit and West Orange, NJ, after completing medical school, residency and fellowship at Johns Hopkins. He is a USSONAR alumnus who utilizes musculoskeletal ultrasound in diagnosis and management of rheumatic disease. He is currently serving as ACR committee member on the Annual Meeting Planning Committee and enjoys advocacy trips to DC with Advocates for Arthritis. He has been a reporter for RheumNow at rheumatology conferences for the past 5 years. Follow him on X at @ericdeinmd.Rebecca Grainger, MB ChB (Dstn), PhD, FRACP, is Professor of Medicine at the University of Otago, Wellington, New Zealand. A University of Otago medical graduate, she undertook rheumatology training in Melbourne and her PhD examined inflammatory mechanisms in gout. Dr. Grainger's clinical work focuses on assessment and management of inflammatory arthritis and her particular clinical interests include inflammatory arthritis, gout, and scleroderma. Dr. Grainger's academic interests are wide but she aims to undertake research in clinical rheumatology, health professions education and technology.  Follow her on X @Drbeckyg and on Bluesky at @profbeckyg.bsky.social.Lakshmi Jayaram, MD, is a clinician educator and Assistant Professor in the Division of Immunology and Rheumatology at Stanford University. Her academic interests are mainly in medical education, quality improvement, patient safety and social determinants of health. As a clinician, she is a general rheumatologist with special interests in myositis, gout, psoriatic arthritis, and vasculitis.Molly Leavitt, MD, MBA, is a first-year rheumatology fellow at the University of South Florida. Her interests include medical education and reproductive health for patients with rheumatic diseases.To learn more about RheumMadness:https://sites.duke.edu/rheummadness/Subscribe to our newsletter:https://lists.duke.edu/sympa/subscribe/rheummadnessFind us on social media:Bluesky: @rheummadness.bsky.socialInstagram: https://www.instagram.com/rheummadness/X: Follow #RheumMadnessIntro/outro music: Cheery Monday by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3495-cheery-mondayLicense: http://creativecommons.or

In this episode, we dive into the cutting-edge advancements presented by Dr. Christopher T. Ritchlin at Convergence 2024, where he shed light on the promising research set to transform the field of rheumatology. Join us as we break down key insights from one of the field's leading experts, exploring the future of precision medicine, the role of TRBV9 cells in axSpA, the impact of sex differences on PsA, and the potential of urinary biomarkers in Lupus Nephritis. Tune in for a fascinating discussion on what's next in rheumatology. 

In this episode, we introduce 2 of our fantastic Blue Ribbon Panel members.  Their full bios are listed below.  You'll meet the rest of the panel in the next episode!Also, RheumMadness brackets are open through March 31 at 11:59pm ET!  Submit your brackets here.First time playing RheumMadness? Check out our new explainer video!Panelists in this podcast:Michele Meltzer, MD, MBE, is an Associate Professor of Medicine at Thomas Jefferson University in Philadelphia, Pennsylvania. She attended Hahnemann Medical School and rheumatology fellowship at Temple University Hospital. In 2007, she completed a Master's of Bioethics at the University of Pennsylvania. Dr. Meltzer has been a ACR committee member of Rheumatologic Care and Ethics and Conflict of Interest committees. She serves as President and founding member of Rheumatology for All, a nonprofit whose mission is to increase access to rheumatology care in resource limited areas. She loves that RheumMadness makes learning about rheumatology fun and is accessible to students worldwide.Lisa Traboco, MD, is a rheumatologist with a passion for digital health, social media, telemedicine, and medical education. She likes to integrate technology into clinical practice and training, as well as participate in systems implementation. She is currently pursuing a Master's in Health Informatics while working at St. Luke's Medical Center – Global City in the Philippines. She is also actively involved in APLAR & has been an exchange scholar to Japan and the ACR. Her interests include learning languages, watching K-dramas & visiting historical museums. Follow her on X at @rheumarhyme and Bluesky at @rheumarhyme.bsky.social.To learn more about RheumMadness:https://sites.duke.edu/rheummadness/Subscribe to our newsletter:https://lists.duke.edu/sympa/subscribe/rheummadnessFind us on social media:Bluesky: @rheummadness.bsky.socialInstagram: https://www.instagram.com/rheummadness/X: Follow #RheumMadnessIntro/outro music: Cheery Monday by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3495-cheery-mondayLicense: http://creativecommons.org/licenses/by/4.0/

In this episode, our host is joined by Dr. Peter Nigrovic, an expert in Macrophage Activation Syndrome (MAS). Dr. Nigrovic, delves into the complexities of MAS. The discussion covers the syndrome's history, diagnostic challenges, mechanisms of inflammation, and the latest treatment strategies, including cytokine blockade, JAK inhibitors, and chemotherapy options. Dr. Nigrovic also reflects on his unique career journey, offering valuable insights into combining clinical practice and research, while sharing his philosophy for a fulfilling life in medicine and science. This episode is a thorough exploration of MAS and provides practical advice for clinicians dealing with this complex syndrome. Macrophage Activation Syndrome 

In the 880th episode of the PokerNews Podcast, Chad Holloway, Kyna England, and Mike Holtz talk about the guy who flipped over three poker tables at the WSOP Circuit Harrah's Cherokee Main Event. See the video and find out what tournament staff did to rectify the situation. The crew then discusses Ebony Kenney getting slammed by poker fans over a recently resurfaced picture of her playing online with GTO Wizard open, and ACR's response to the most recent RTA controversy. Other topics include a potential angle shoot on The Lodge Live Stream, Ali Imsirovic being DQ'ed from a Texas tournament and then being banned from the cardroom, and big winners from the 6th Annual Global Poker Awards that took place this past Saturday at PokerGO Studio in Las Vegas.  Plus, hear about Kyna attending a Charity Series of Poker (CSOP) event alongside Phil Ivey and his family, Joey Weissman crushing the PokerGO Cup, and it's your last chance to enter our giveaway for The Las Vegas Book. The podcast is sponsored by the #1 free-to-play WSOP app. Remember to use the bonus code "POKERNEWS" if you download and play for an extra 1,000,000 in chips! A new PokerNews Podcast will drop weekly every Friday at 8a PT / 11a ET / 4p UK time. Remember to subscribe to our YouTube channel so you do not miss an episode! Time Stamps *Time | Topic* 01:12 | Welcome to the show 01:25 | The crew is in the studio 02:00 | Player flips over three tables at WSOP Circuit Harrah's Cherokee 07:46 | Sponsor: WSOP Free-to-Play App 08:00 | Poker fans slam Ebony Kenney, ACR's response to RTA controversy 09:12 | ACR issues statement 11:10 | Disgusting responses turn personal 12:53 | What to do about GTO Wizard 14:57 | Was it an angle shoot on The Lodge live stream? 22:00 | Daniel Wojcik wins title at The Lodge 23:02 | Ali Imsirovic DQ'ed from Texas tournament and then banned from cardroom 25:31 | Skull Mike, Slick Rick & Matt Sweeney win Global Poker Award for Best Live Stream 26:00 | PokerNews Podcast stylin' and profilin' at Global Poker Awards 26:57 | PokerNews Yori Epskamp presents award; shoutout to GPI crew, Jeff Platt & Drea Renee 30:57 | Kyna attends CSOP event; Phil Ivey & family also there 33:13 | Joey Weissman conquers the PokerGO Cup with legendary performance 35:58 | Winners from the PokerGO Cup 36:51 | Florian Pesce wins WSOP Circuit Harrah's Cherokee $1,700 Main Event 37:44 | Tilted Compass hoodies for everyone! 38:16 | Last chance to enter our giveaway for The Las Vegas Book

In this episode, we explore a potential paradigm shift in the treatment of Rheumatoid Arthritis. For years, pharmacologic interventions have been the cornerstone of management, but now a groundbreaking approach is emerging. John Tesser, principal investigator in a pioneering study, discusses the use of an implantable device that stimulates the vagus nerve. By tapping into the body's nervous system to reduce inflammation, this novel approach offers a promising alternative to traditional drug treatments. Tune in to learn how this innovative technology could reshape the future of Rheumatoid Arthritis care. 

One subscriber to my Inner Circle Newsletter, while he cared about his clients and helped grow their wealth, struggled with a mental block that robs more advisors every day than I can keep track of.  The mental block?  Needing permission to do, well, any action that could grow your business by a scary amount.  These advisors are waiting for a golden ticket. They think the universe will see all their hard half-work they didn't finish and reward them with entry into the knighthood of the wealthiest advisors.  And so, they sit around, and wait. And wait. And wait.  Until one day, many years later, they wake up from this stupor and realize that a “hope and pray” marketing strategy is good for one thing: Bankrupting your business.   If that sounds like you, don't worry. Today's show will help you remove this mental block before it suffocates your advisory business.  Listen now. Show highlights include: The insidious “prospecting reluctance” trap advisors fall in that destines them to a mediocre business (3:12)  The #1 biggest obstacle to your success (and it's not your market, your competitors, or your current clients) (4:28) How to become wealthy beyond your wildest dreams when a guru hasn't blessed your strategy, you don't have a fancy title, and you lack real experience (4:51)  Why seeking credentials, while important for credibility, becomes a crutch to feed your procrastination (5:02)  The emotional mindset shift that's the main difference between an advisor worth $10 million and one worth $50,000 (7:45) The “ACR” secret from psychology that shows you how to be wealthy, fulfilled, and happy—at the same time (12:57)  The 3 most common signs you're subconsciously seeking permission (19:24)  Since you listen to this podcast, I want to give you a gift:  If you subscribe to the Inner Circle Newsletter, I'll send you a collection of seven “objection busting” and copyright free emails, personally written by me, that you can use right away to begin getting more clients. Sign up here: https://TheAdvisorCoach.com/Coaching. Then, let me know you subscribed, and I will reply back with a link where you can download them for free. 

Explore how the American College of Radiology (ACR) is tackling one of the most pressing questions in healthcare: does AI truly improve outcomes for radiologists and patients? In this interview, Dr. Bernardo Bizzo, Associate Chief Science Officer at the ACR's Data Science Institute, dives into the work his team is doing to rigorously evaluate AI tools for radiology. Hear about the ACR's hands-on approach to testing AI in real-world clinical settings, their findings so far, and how they're helping radiologists navigate the rapidly evolving world of AI. If you're curious about the practical impact of AI in radiology and what lies ahead, this is a conversation you won't want to miss.Learn more about ACR athttps://www.acr.org/Learn more about ACR DSI athttps://www.acrdsi.org/Find more great health IT content athttps://www.healthcareittoday.com/

Topic begins at (0:04:22) mark: Where has PFA Radio been? Why it's been a staggering 7 weeks since the last episode, and what can you expect in the future?.... (0:46:02): ACR pro "Nacho" Barbero in controversy after photo of his online play shows GTO Wizard on his screen.... (1:22:50): Famed Supreme Court lawyer Thomas Goldstein in trouble with IRS for evading taxes on poker winnings & paying chicks to date him.... (2:22:17): Gambling coaching scammer Christopher Mitchell loses Facebook acccount after attacking PFA regular Lee Bradbury in weird rant.... (3:04:14): Jamie Gold cares about your teeth and gums.... (3:21:07): Well-liked old school poker figure "Miami" John Cernuto said to be on hospice care, then passes away.... This is part 1 of the show. Part 2 will be posted as a separate episode within a few days.

Los conciertos de Fillas de Cassandra pretenden ser un festejo colectivo y catártico. Su álbum debut, ACRÓPOLE, rinde homenaje a las heroínas de la mitología griega. Su música se inspira en ese bagaje clásico y también toma la tradición de su tierra, Galicia, para contraponerla con la contundencia del techno. Su presencia escénica es rompedora y apabullante y consiguen conectar con el público gracias a sus letras directas y emotivas.Escuchar audio

In the 877th episode of the PokerNews Podcast, which has been nominated for 'Podcast of the Year' at the Global Poker Awards, Chad Holloway, Kyna England, and Mike Holtz discuss ACR calling Nacho Barbero a "goofball" after serious accusations arose when the Argentinean pro shared a social media post that showed him using GTO Wizard. Patrick Leonard did a deep dive into the data, and while it apparently shows no nefarious activity, it did get the community questioning the situation as a whole.  Chad and Kyna also share their experience at the massive MSPT Potawatomi, which saw them both cash on just one bullet apiece. Get a look at their Wisconsin adventure, and find out where they each finished. They also highlight the winner of that tournament as well as Angela Jordison, who took down a side event. The crew then shows some love for the Venetian Poker Room, examines a big hand between Doug Polk and Mariano that was live-streamed from The Lodge, and Leon Tsoukernik feeling 'Absolutely Fine' two weeks after a 40-hour coma. Finally, get a look at Phil Galfond on the latest Life Outside Poker episode as well as a reminder to enter the PokerNews Giveaway for a copy of The Las Vegas Book valued at $500. The podcast is sponsored by the #1 free-to-play WSOP app. Remember to use bonus code "POKERNEWS" if you download and play for an extra 1,000,000 in chips! A new PokerNews Podcast will drop weekly every Friday at 8a PT / 11a ET / 4p UK time. Remember to subscribe to our YouTube channel so you do not miss an episode! Time Stamps *Time | Topic* 00:11 | Welcome Kyna England & Mike Holtz 00:37 | Nacho Barbero in hot water over GTOWizard 07:03 | Patrick Leonard dives in; shares results 07:23 | The economy of an online poker site 08:28 | ACR's poor response 12:04 | Sponsor – WSOP Free-to-Play App 12:52 | Major poker tournament returns to Wisconsin 14:00 | Kyna tries to organize a 30-way chop 15:18 | Massive turnout in the $1,110 Main Event 15:56 | Highlights from the MSPT Potawatomi 17:30 | Both Chad & Kyna cash on one bullet 18:30 | Tim Thorp wins MSPT Potawatomi for $244K 18:50 | Umut Ozturk makes back-to-back final tables; in POY lead again 19:53 | Angela Jordison ships side event at MSPT 20:50| Love for the Venetian Poker Room 23:32 | Doug Polk vs Mariano in big live-streamed hand from The Lodge 28:42 | Leon Tsoukernik feeling 'Absolutely Fine' two weeks after 40-hour coma 30:31 | Phil Galfond on the latest Life Outside Poker Podcast 33:00 | PokerNews Giveaway – The Las Vegas Book

Welcome to The LA Poker Roundup! The place for recent news and events in the LA poker community, with a focus on tournaments. This show will go over events happening the following week, the pros and cons of different events along with the opinions of your hosts. This week: 02:08 Intro 04:30 Results from the Bike Dailies 14:55 Results from the Gardens Dailies 18:00 Results from LAPC 32:40 Brian Hastings Joins the Roundup to talk mixed games structures! 39:45 Savage Average for mixed games 48:30 Structures impacting new mixed players taking a shot? 56:06 ACR Pro Nacho posts picture of GTO Wizard next to his ACR clients 1:02:00 Cheating squeezing the life out of online? 1:08:45 The Lodge runs a Mystery Bounty Chaos Event 1:15:38 Savage weighs in on rules around Table Talk 1:21:40 Ty hates the name of the XXL Bounty tournament 1:27:43 Weekly Roundup Remember to subscribe and turn on notifications to catch each Roundup every week. Follow us on Twitter and Instagram LAPR Instagram: https://www.instagram.com/lapokerroundup/ Ty's Twitter: https://twitter.com/TyDobbertin Ty's Instagram: https://www.instagram.com/tydobbertin/ Derek's Twitter: https://twitter.com/kwansfull Derek's YouTube: https://www.youtube.com/@kwansfull Derek's Instagram: https://www.instagram.com/kwansfull/​

Last show of the month and we were lucky two get two guests on the show, em_laa and Jeremy Sylvester.  The first show on VBR was a new mix of new(ish) tracks, so that leaves this week for crate digging and boy did we dig!  At least three quarters of the mix is vinyl as I didn't switch to digital until 2005 and most of these tracks are much older than that.No preconceptions of what I was gonna play or even the style.We started super chill with Karizma's remix of John Legend's - Ordinary People.  By track four we'd gone all the way back to the early 90's and that's where we spend a lot of the first half of the mix.  The US garage sound of the early 90's reigns supreme with classic after classic raining down.We then transition across the pond to my homeland for the UK garage equivalent with mid 90's classics on the menu.We'll do it all again next month, but for now I'm gonna call the first month on VBR a roaring success.  There's a great energy and real buzz on the station.  The chatroom seems to always be busy and everyone is so supportive of each other.Congratulations Andy.Tracklisting:1: John Legend - Ordinary People (Karizma Kayorican Remix)2: Real People - Alibi (Dennis F's Out In Bali Mix)3: Fuminori Kagajo ft Adeola Ranson - Piece Of Heaven (Sean McCabe Dub Mix)4: Seven Grand Housing Authority - The Question (Terrence Parkers Orig)5: DJ Man-X & Vick Lavender ft Shawnee Taylor - Happy Endings (Frankie Feliciano Classic Vocal)6: Shawn Christopher - Make My Love (Stonebridge Main Mix)7: MK - Burning8: Clubland - Lovetrain (Def Mix)9: Nush - Nush10: ACR - 27 Forever11: Buster Gut - Find Someone12: Darryl James - You Make Me Happy (Todd Terry)13: Smooth Touch - House Of Love14: Sagat - Luv Stuff15: Carleen Anderson - Mamma Said (K Klassic Mix)16: c2eMusic - Beautiful Person17: Roger S - Time To Stop18: Gusto - Disco's Revenge19: The Bucketheads - The Bomb20: That Kid Chris - Feel The Vibe21: Ground 96 - Love Has Taken Over22: Todd Edwards - Push The Love23: ???  NNR tune - I think by J Sylvester.24: TJR - Just Gets Better25: R.I.P. Productions - You Cheated26: Smokin Beats - Dreams27: Simpson Tune - Bring It Down (Da BMR's Club Rework)Enjoy!

If you're a healthcare provider or a storytelling enthusiast, you'll enjoy this episode featuring Dr. Jason Liebowitz. A practicing rheumatologist and accomplished writer, Dr. Liebowitz discusses his journey toward becoming a physician-writer, how writing helps him process his experiences, and the art of storytelling in medicine, especially for a wider audience in today's complex healthcare landscape. 

In this episode we explore the role of Neutrophil Extracellular Traps (NETs) in systemic lupus erythematosus (SLE). Dr. Mariana Kaplan, Chief of the Systemic Autoimmunity Branch at the National Institute of Arthritis Musculoskeletal and Skin Diseases, joins the discussion to break down the complex immunological mechanisms driving lupus, focusing on the contribution of NETs and Low-Density Granulocytes (LDGs) to disease activity and tissue damage. The conversation delves into the potential for these biological markers to improve diagnosis and treatment strategies, particularly in the context of lupus flares and cardiovascular complications. A link to this week's article can be found, here: Exploring the Role of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus: A Clinical Case Study and Comprehensive Review 

Happy New Year, Dear Listener! We're back for 2025 and have with us Dr. Carol Langford, President of The American College of Rheumatology (ACR) and Dr. Adam Goode, President of The Association of Rheumatology Professionals (ARP) as our guests. In this episode you'll get an in-depth look at the collaborative efforts driving the ACR and ARP, direct from our leadership!   Dr. Langford and Dr. Goode share with us their journeys into leadership, key initiatives for this year and their vision for advancing the field of rheumatology. We'll also discuss workforce shortages, technological advancements affecting our field and fostering a more inclusive community. 

ACR & Phil Nagy Are Being SUED ! Only Friends Pod Ep 652 Solve For Why by Solve For Why

In this Conversations in IFN-y podcast episode, emerging data from the 2024 ACR meeting is discussed, highlighting advancements in understanding genetic drivers, cytokine dynamics, and biomarkers like IL-18 and CXCL9 for improved diagnosis and monitoring. Expert insights explore new findings on liver and lung pathology in MAS, as well as updates on therapeutic innovations, including JAK inhibitors and emapalumab, and their roles in enhancing patient outcomes. Practical strategies are provided for integrating the latest research and cutting-edge diagnostics into clinical practice.Launch Date: December 19, 2024Release Date: December 19, 2024Expiration Date: November 30, 2025FACULTYPui Lee, MDAssistant Professor of PediatricsBoston Children's HospitalAlexei Grom, MDProfessor of PediatricsResearch DirectorDivision of RheumatologyCincinnati Children's Hospital Medical CenterThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

This year at ACR24, the RheumNow faculty and reporters were prolific, generating 800 Tweets, 56 written articles, 117 Videos and 28 podcasts – all in 4 days!  You can best review and learn ACR 2024 by A) Rheumatology Roundup; b) TOPIC Panel podcasts; and c) Topic podcasts. This weeks notable citations on RheumNow.com

As 2024 ends, the ACR's Government Affairs Committee looks ahead to the 119th Congress to address key issues in rheumatology. For our second annual legislative and policy update, we're joined by Dr. Lennie McDaniel, head of ACR's Washington DC office, and Dr. Christina Downey, Chair of the Government Affairs Committee, to share insights from their ACR Convergence 2024 session. Topics include Medicare cuts, physician payments, pharmacy benefit managers (PBMs), telemedicine reimbursement changes, and how you can advocate for better outcomes with the ACR. 

Highlight presentations from ACR 2024 in Washington, DC Covered abstracts include: - Dr. Kavanaugh 1679 Amplified & biomarkers 0082 Enthesitis Pathology & IL-23 1553 TLR 7/8 inhibitors in SLE 995 Carbon footprint to injectables L20 ARTHUR DIANA Automated US 1132 VEGA (Combo Rx – see also 2640, 1460, 1393) 1745 Statin use in Oral Surveillance - Dr. Cush 458 Seronegative RA fate L19 Emapalumab in Stills disease ACR 2024 updated guidelines on lupus nephritis 2580 Ianalumab in SLE 2259 Anti-Obesity Meds in RA 2657 Mortality with starting/stopping steroids 0774  TAPIR study in GCA 1697  PMR MODE study

In this episode, we explore the findings of a groundbreaking study analyzing opioid treatment trends for adults with and without systemic autoimmune and inflammatory rheumatic diseases (SARDs) from 2006 to 2019. The study, based on national data from the United States, sheds light on how individuals with conditions like rheumatoid arthritis, lupus, and ankylosing spondylitis are impacted by opioid use compared to the general population. 

This episode features a conversation with Captain Bobby Abruscato, a long-time inshore and offshore fishing guide in Alabama. He discussed the current fishing conditions in the area, noting that the warm weather has kept the fishing in a late summer/early fall pattern, with anglers still finding good numbers of speckled trout and redfish feeding on shrimp. Captain Bobby explained that as the water temperatures start to drop with the upcoming cold front, the shrimp will begin to thin out and the fishing will transition, with anglers needing to switch to tactics like topwater lures, jigs, and soft plastics to target the trout and reds. He provided detailed tips on techniques like the "do nothing drift" for fishing deep river channels in the winter. The hosts also discussed the importance of boating safety and emergency preparedness, including the essential gear that should be kept in a well-stocked "ditch bag" on the boat. They were joined by ACR Electronics to talk about Ditch Bags and the importance of having one. Mikele D'Arcangelo with ACR provides expert advice on items like EPIRBs, PLBs, and other communication and signaling devices that can be critical in an emergency situation offshore.

In this special episode of the Refresh by AdTechGod, we discuss The Trade Desk's big announcement about Ventura, their new TV operating system set to drop in 2025. We chat about what this means for the connected TV (CTV) space; everything from possible conflicts of interest and the role of OEMs to how it might shake up the user experience. The panel takes a closer look at the challenges and opportunities this new OS brings, including the need for better interoperability and smarter monetization strategies. We also touch on the current state of CTV, how consumer experiences are becoming more commoditized, and what The Trade Desk's strategy might mean for the market. Thats not all! There's talk about publisher monetization struggles, discoverability issues, and how AI could step up to improve user experiences. Thank you to my guests: Tony Marlow from LG Ad SolutionsScott Ensign from Butler/TilShiv Gupta from U Of Digital. Thank you to Azerion for Sponsoring this episode. TakeawaysTrade Desk's Ventura aims to disrupt the existing OS landscape.The success of CTV advertising relies on user experience and hardware.Partnerships with OEMs are crucial for Trade Desk's strategy.The CTV market is currently chaotic and needs order.Trade Desk's entry could increase competition among existing OS providers.The narrative of being agnostic may be challenged by Trade Desk's new role.Agencies see potential benefits in Trade Desk's ownership of technology.Distribution is key to the success of any new OS.The TV hardware market is highly competitive and low-margin.Improving user experience is essential for the growth of CTV. The consumer experience in CTV is currently commoditized.Publisher monetization is becoming increasingly complex.Trade Desk's strategy focuses on enhancing backend value.AI integration is key to improving content discoverability.The CTV market is ripe for innovation and disruption.Increased competition can lead to better products and services.Trade Desk's OS aims to control the CTV ecosystem.The future of CTV may see significant local media growth.Understanding user experience is crucial for CTV success.The transition from cookies to ACR data is essential for programmatic advertising.Chapters00:00 Introduction and Upcoming Events06:57 The Conflict of Interest in CTV Advertising14:56 Partnership Dynamics Between Trade Desk and OEMs20:14 Market Dynamics and User Experience in CTV25:15 The Commoditization of Consumer Experience in CTV32:12 Trade Desk's Strategy and Market Positioning40:20 The Future of CTV: Opportunities and ChallengesKeywords:Trade Desk, Ventura, CTV, advertising, operating system, LG ads, Sonos, agency perspective, market dynamics, user experience, CTV, Trade Desk, consumer experience, advertising, market competition, AI, discoverability, monetization, programmatic, user experience, AdTechGod

ACR 24: What I learned in Sjogren's, Takayasu's and CAR-T:Dr. Janet Pope Anti IL-17 on Entheseal Biopsy in PsA:Dr. Eric Dein  axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure:Dr. Brian Jaros Can We Make Clinical Trials Better?:Dr. Janet Pope Cumulative Steroid Use and Cardiovascular Events:Dr. Mrinalini Dey  IL 6 Inhibitors, Frailty and Polymyalgia Rheumatica:Drs. Trish Harkins and Sebastian Sattui IVIG Treatment in Immune-mediated Necrotizing Myopathy:Drs. Caoilfhionn Connolly interviews Dr. Asim Mohamed  Machine Learning for Predicting Flares in axSpA:Dr. Sheila Reyes So really, are JAKs Safe?:Dr. Janet Pope Tackling the Workforce Crisis: A shared dilemma:Drs. Mrinalini Dey,  Louise Pollard and Bharat Kumar The 2024 ACR Guidelines for Lupus Nephritis:Dr. Sheila Reyes  The Real Value of JAKi is Beyond RA:Dr. David Liew  Vaccine Responses:The DMARD Counts:Dr. David Liew

Alternate Current Radio Presents: Boiler Room - Learn to protect yourself from predatory mass media.Bryan 'Hesher' McClain, Adam 'Ruckus' Clark & 'Simon From Florida' open the Boiler Room for a discussion on the United States via the Biden administration allowing & supporting Ukraine to use long range missiles to strike inside of Russian territory. Simon breaks down, in its entirety, Russia's new 'Nuclear deterence' doctrine and framework put into legal effect TODAY. What does this mean for the Russia/Ukraine conflict, for NATO allied countries and for Russia allied countries? All this and more... on this episode of Boiler Room.Alternate Current Radio Webpage: https://www.alternatecurrentradio.com/Support BOILER ROOM & ACR: https://www.alternatecurrentradio.com/donate/Patreon: https://www.patreon.com/alternatecurrentradioShop BOILER ROOM Merch Store: https://www.alternatecurrentradio.com/shop/

We're reporting live from the American College of Rheumatology (ACR) Convergence 2024 in Washington, D.C., a yearly gathering for rheumatology experts worldwide. Join us as we talk to rheumatologists, researchers, and patients to discover how these advancements in research are shaping the future of health and advocacy. Among the highlights in this episode: 00:43: Dr. Sharon Dowell discusses her background as a rheumatologist and her favorite ACR session, "Thieves Market," which emphasizes the diversity of rheumatology cases 01:27: Dr. Dowell explains how events like ACR enhance advocacy by providing opportunities for networking and sharing global perspectives on patient care 02:24: Dr. Swamy Venuturupalli shares his excitement about lupus-specific sessions, especially on CAR T cell therapy, and how these advancements could help his patients 03:36: Dr. Venuturupalli emphasizes the importance of ACR as a global platform for learning and collaboration in rheumatology research 04:25: Cristina Montoya, a registered dietitian and patient advocate, shares her experience presenting on unrecognized symptoms of rheumatic diseases 05:29: Cristina highlights her work with the OMERACT Children's Disease Working Group and her contributions to developing new outcomes for clinical trials 06:44: Dr. Shilpa Venkatachalam reflects on the patient-centered focus at ACR 2024 and the collaborative advancements in biologics and treatment modalities 09:02: Dr. Venkatachalam explains the value of patient-centered research in making invisible diseases visible through patient-reported outcomes and clinical data 12:06: Dr. Venkatachalam discusses how tools like PatientSpot empower patients to advocate for themselves by providing a full picture of their lived experiences For more information about PatientSpot, visit: https://patientspot.org/ 13:14: Zoe wraps up the episode, emphasizing the significance of research presented at ACR in improving patient outcomes and advocacy efforts Contact Our Hosts Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org Zoe Rothblatt, Director of Community Outreach at GHLF: zrothblatt@ghlf.org A podcast episode produced by Ben Blanc, Associate Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

We are proud to present the highly anticipated “ACR 2024 Lupus Nephritis Guideline” with First Author and frequent guest, Dr. Lisa R. Sammaritano. A decade in the making, we reflect on the significant advancements in available therapies, the guideline's holistic approach to managing Lupus Nephritis (LN) across all age groups, and include insights on combination therapies, minimizing glucocorticoid use and how to manage the full spectrum of patients with Lupus Nephritis. 

As we continue to highlight sessions from Convergence 2024, we came upon this talk we think you should not miss: Emerging Threats in Rheumatology: Chronic Chikungunya Arthritis and Syphilis Mimicking Rheumatic Diseases. Session presenters, Dr. Jose Kennedy Amaral Pereira and Dr. Daniela DiMarco help us explore the world of emerging threats in rheumatology: specifically, Chikungunya Arthritis and Syphilis. These two experts share insights with us to help diagnose and manage those with these devastating infections and highlight for us how important it is for rheumatologists to remain on high alert for these infections, which can be easily mistaken for more common rheumatic disorders! 

ACR 2024 starts tomorrow; here are a few previews of Abstracts to be presented. Along with my recommendations of sessions you don't want to miss.  

This week we're joined by two leading experts in gout remissions, Dr. Nicola Dalbeth and Dr. Dansoa Tabi-Amponsah to explore the exciting advances in gout treatment, with a particular focus on Dual-Energy CT (DECT) imaging and its role in achieving gout remission. We dive into how DECT technology is transforming our ability to visualize urate crystals in joints, its implications for patient care, and the potential it holds for long-term gout management and remission. 

When should we choose rituximab over cyclophosphamide? What role can avacopan play as an adjunct therapy? When is plasma exchange a viable option? How can we effectively navigate steroid tapering? These are just a few of the critical questions we'll explore with our next guest, Dr. Tanaz Kermani, founder and director of the Vasculitis Program at UCLA, a dedicated clinician and active researcher. Join us as we delve into these topics and address the challenges of diagnosing and managing patients with vasculitis. 

Clayton Fletcher (@claytoncomic) welcomes THREE surprise guests to the podcast, recorded on location after a highly unusual comedy show at Lonerider Brewery in Raleigh, North Carolina.----Register for GTO Wizard and save 10% off your first purchase using this link: https://gtowizard.com/p/tpe----Come see Clayton perform stand-up!!!   linktr.ee/claytoncomic----Play on ACR using the promo code TPE for a 100% first-time deposit bonus up to $2,000.00 USD:  https://bit.ly/2Wvb6Vb----Join the Tournament Poker Edge discord channel:https://t.co/JHEUIHrCrJ

Clayton Fletcher (@claytoncomic) answers a few select strategy questions from the TPE Discord.----Register for GTO Wizard and save 10% off your first purchase using this link: https://gtowizard.com/p/tpe----Tickets to see Clayton perform stand-up!!!   linktr.ee/claytoncomic----Play on ACR using the promo code TPE for a 100% first-time deposit bonus up to $2,000.00 USD:  https://bit.ly/2Wvb6Vb----Join the Tournament Poker Edge discord channel:https://t.co/JHEUIHrCrJ